Back to Search
Start Over
The ICER review is in: hope amidst uncertainty.
- Source :
-
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Jan; Vol. 28 (1), pp. 115-118. - Publication Year :
- 2022
-
Abstract
- DISCLOSURES: No funding contributed to the writing of this commentary. Smith Begolka, Butler, and Guadalupe are salaried employees of the National Eczema Association, which has received grants and sponsorship awards from a variety of industry partners, including AbbVie, Eli Lilly, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi. Smith Begolka has received grant funding from Pfizer and advisory board honoraria from Pfizer and Incyte. Butler and Guadalupe have received advisory board honoraria from Incyte.
Details
- Language :
- English
- ISSN :
- 2376-1032
- Volume :
- 28
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of managed care & specialty pharmacy
- Publication Type :
- Academic Journal
- Accession number :
- 34949117
- Full Text :
- https://doi.org/10.18553/jmcp.2022.28.1.115